Anbieter: Better World Books Ltd, Dunfermline, Vereinigtes Königreich
EUR 28,98
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. 2nd ed. Ships from the UK. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.
EUR 31,28
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. pp. 308 Illus.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Verlag: London, Springer London/Imprint: Springer., 2002
ISBN 10: 1852332298 ISBN 13: 9781852332297
Sprache: Englisch
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
Erstausgabe
1st ed. 2002. Softcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Verlag: London, Springer, 2006
Sprache: Englisch
Anbieter: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Deutschland
Verbandsmitglied: GIAQ
EUR 6,72
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Wie neu. 2nd ed. 274 S.; Ill. Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 630.
Taschenbuch. Zustand: Sehr gut. 256 Seiten ex Library Book aus einer wissenschafltichen Bibliothek Sprache: Englisch Gewicht in Gramm: 523.
Softcover. Zustand: Wie neu. Gebraucht - Wie neu Mängelex.: Lagerspuren, Zustand: Gut, XIII, 258 pp. 48 figs. About this book: Clinical Trials in Osteoporosis is a practical handbook on clinical trials in the growing field of osteoporosis. Topics covered include study design, technical issues, data collection, quality assurance, data analysis and presentation. It aims to take the user through the process step-by-step from start to finish, also providing a background on regulatory guidelines, ethical implications, endpoints, current therapies and the ideal drug to use. There are no other books at present that specifically address the issue of clinical trials in osteoporosis. A number of issues dealt with in this book have been brought together in one publication for the first time. Clinical Trials in Osteoporosis is intended to serve as a practical manual for clinicians and scientists coming to the subject new and to provide a standard for existing centers to measure themselves against. Written for rheumatologists, endocrinologists, obstetrics & gynecology specialists.
EUR 117,81
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. pp. xiii + 258 Illus.
soft cover. Zustand: Wie neu. Gebraucht - Wie neu -COLING. MILLER ANDDEREKPEARSON 1. 1. Why a Book about Clinical Trials in Osteoporosis There have been many books published about the design, conduct, and analysis of clinicaltrials. Whyareosteoporosistrialsaspecialcasethatdeserveabookoftheir own There are three main reasons. First, most diseases have a well-understood definitionandaetiology. Osteoporosisisadiseasethatisunderstoodbythosewo- ing within the subspecialty, but currently there is no definition that is agreeable to both medical and scientific communities and its aetiology is poorly understood. It is within this framework that the pharmaceutical industry is trying to develop new treatmentsfortheso-called'silentepidemic'. In layman's terms, the disease of osteoporosis is defined as 'brittle bones occurring in the elderly that could lead to fractures. 'The classical definition was 'a bony fracture caused by minimal trauma owing to a loss in bone mineral. ' A published consensus definition states that osteoporosis is 'a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to 1 fractures. ' The National Institutes of Health (NIH) Consensus Conference Statement on Osteoporosis Prevention, Diagnosis, and Therapy states that 'osteoporosis is a skeletal disorder characterized by compromised bone strength 2 predisposing to an increased risk of fracture. ' The World Health Organization (WHO) operationally defines osteoporosis as 'bone density 2. 5 standard dev- tions (SDs) below the mean for young white adult women at lumbar spine, 3 femoralneck,orforearm'. Itisnowrecommendedthatthediagnosticuseofthis 4 definition is restricted to bone density of the femur.
EUR 123,95
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. A practical manual for clinicians/scientists coming to the subject new - provides a standard for existing centers to measure themselves againstSpecifically addresses clinical trials in osteoporosis (no such other book is in the Library of Congress.
Taschenbuch. Zustand: Neu. Neuware - COLING. MILLER ANDDEREKPEARSON 1. 1. Why a Book about Clinical Trials in Osteoporosis There have been many books published about the design, conduct, and analysis of clinicaltrials. Whyareosteoporosistrialsaspecialcasethatdeserveabookoftheir own There are three main reasons. First, most diseases have a well-understood definitionandaetiology. Osteoporosisisadiseasethatisunderstoodbythosewo- ing within the subspecialty, but currently there is no definition that is agreeable to both medical and scientific communities and its aetiology is poorly understood. It is within this framework that the pharmaceutical industry is trying to develop new treatmentsfortheso-called'silentepidemic'. In layman's terms, the disease of osteoporosis is defined as 'brittle bones occurring in the elderly that could lead to fractures. 'The classical definition was 'a bony fracture caused by minimal trauma owing to a loss in bone mineral. ' A published consensus definition states that osteoporosis is 'a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to 1 fractures. ' The National Institutes of Health (NIH) Consensus Conference Statement on Osteoporosis Prevention, Diagnosis, and Therapy states that 'osteoporosis is a skeletal disorder characterized by compromised bone strength 2 predisposing to an increased risk of fracture. ' The World Health Organization (WHO) operationally defines osteoporosis as 'bone density 2. 5 standard dev- tions (SDs) below the mean for young white adult women at lumbar spine, 3 femoralneck,orforearm'. Itisnowrecommendedthatthediagnosticuseofthis 4 definition is restricted to bone density of the femur.